InsidersTradesSigma
Follow the 에이프릴바이오 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 에이프릴바이오 has recorded 8 insider filings. Market capitalisation: €421.6bn. The latest transaction was disclosed on 10 June 2026 (Sale). Among the most active insiders: 에스엠시노기술투자. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
April Bio is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative biopharmaceutical solutions.